Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 119

1.

Global Proteomic Profiling of Salmonella Infection by a Giant Phage.

Weintraub ST, Mohd Redzuan NH, Barton MK, Md Amin NA, Desmond MI, Adams LE, Ali B, Pardo S, Molleur D, Wu W, Newcomb WW, Osier MV, Black LW, Steven AC, Thomas JA.

J Virol. 2019 Feb 19;93(5). pii: e01833-18. doi: 10.1128/JVI.01833-18. Print 2019 Mar 1.

2.

Whole-Genome Sequences of Salmonella enterica subsp. enterica Serovar Typhimurium Strains TT6675 and TT9097 Employed in the Isolation and Characterization of a Giant Phage Mutant Collection.

Gan HM, Eng WWH, Barton MK, Adams LE, Samsudin NA, Bartl AJ, Hudson AO, Savka MA, Thomas JA.

Genome Announc. 2017 Aug 24;5(34). pii: e00857-17. doi: 10.1128/genomeA.00857-17.

3.

Encouraging long-term outcomes reported in patients with stage I non-small cell lung cancer treated with stereotactic ablative radiotherapy.

Barton MK.

CA Cancer J Clin. 2017 Sep;67(5):349-350. doi: 10.3322/caac.21375. Epub 2017 Jul 11. No abstract available.

4.

Primary tumor location found to impact prognosis and response to therapy in patients with metastatic colorectal cancer.

Barton MK.

CA Cancer J Clin. 2017 Jul 8;67(4):259-260. doi: 10.3322/caac.21372. Epub 2017 May 26. No abstract available.

5.

Symptoms, cancer-related distress, and overall distress may contribute to racial disparities in the outcomes of patients with early-stage breast cancer.

Barton MK.

CA Cancer J Clin. 2017 Jul 8;67(4):257-258. doi: 10.3322/caac.21371. Epub 2017 May 26. No abstract available.

6.

Evidence accumulates indicating periodontal disease as a risk factor for colorectal cancer or lymphoma.

Barton MK.

CA Cancer J Clin. 2017 May 6;67(3):173-174. doi: 10.3322/caac.21367. Epub 2017 Mar 8. No abstract available.

7.

Health behaviors not significantly changed by direct-to-consumer genetic testing.

Barton MK.

CA Cancer J Clin. 2017 May 6;67(3):175-176. doi: 10.3322/caac.21368. Epub 2017 Mar 8. No abstract available.

8.

Cancer cachexia awareness, diagnosis, and treatment are lacking among oncology providers.

Barton MK.

CA Cancer J Clin. 2017 Mar;67(2):91-92. doi: 10.3322/caac.21364. Epub 2017 Jan 17. No abstract available.

9.

Local consolidative therapy may be beneficial in patients with oligometastatic non-small cell lung cancer.

Barton MK.

CA Cancer J Clin. 2017 Mar;67(2):89-90. doi: 10.3322/caac.21363. Epub 2017 Jan 17. No abstract available.

10.

Pretreatment expectations of side effects from endocrine therapy found to influence occurrence.

Barton MK.

CA Cancer J Clin. 2017 Jan;67(1):5-6. doi: 10.3322/caac.21360. Epub 2016 Oct 27. No abstract available.

11.

Disparities found in chemotherapy administration for human immunodeficiency virus-associated lymphoma.

Barton MK.

CA Cancer J Clin. 2017 Jan;67(1):3-4. doi: 10.3322/caac.21359. Epub 2016 Oct 27. No abstract available.

12.

The Arabidopsis transcription factor ABIG1 relays ABA signaled growth inhibition and drought induced senescence.

Liu T, Longhurst AD, Talavera-Rauh F, Hokin SA, Barton MK.

Elife. 2016 Oct 4;5. pii: e13768. doi: 10.7554/eLife.13768.

13.

Study suggests it is safe to ease neutropenic restrictions.

Barton MK.

CA Cancer J Clin. 2016 Nov 12;66(6):441-442. doi: 10.3322/caac.21312. Epub 2016 Sep 6. No abstract available.

14.

Disparities found in perception of symptoms between patients and oncology team.

Barton MK.

CA Cancer J Clin. 2016 Nov 12;66(6):439-440. doi: 10.3322/caac.21311. Epub 2016 Sep 6. No abstract available.

15.

Delivery of neoadjuvant chemoradiation for patients with stage II and III rectal cancer is suboptimal.

Barton MK.

CA Cancer J Clin. 2016 Sep;66(5):357-8. doi: 10.3322/caac.21309. Epub 2016 Jul 1. No abstract available.

16.

Ovarian function suppression is beneficial in some premenopausal women with early breast cancer.

Barton MK.

CA Cancer J Clin. 2016 Sep;66(5):355-6. doi: 10.3322/caac.21308. Epub 2016 Jul 1. No abstract available.

17.

Rates of testing for BRCA mutations in young women are on the rise.

Barton MK.

CA Cancer J Clin. 2016 Jul;66(4):269-70. doi: 10.3322/caac.21306. Epub 2016 May 5. No abstract available.

18.

Bankruptcy linked to early mortality in patients with cancer.

Barton MK.

CA Cancer J Clin. 2016 Jul;66(4):267-8. doi: 10.3322/caac.21305. Epub 2016 May 5. No abstract available.

19.

First-line low-dose morphine is better for the control of moderate cancer pain than weaker opioids.

Barton MK.

CA Cancer J Clin. 2016 May;66(3):177-8. doi: 10.3322/caac.21303. Epub 2016 Mar 21. No abstract available.

20.

Use of posttreatment imaging and biomarker testing for survivors of breast cancer.

Barton MK.

CA Cancer J Clin. 2016 May;66(3):175-6. doi: 10.3322/caac.21302. Epub 2016 Mar 17. No abstract available.

21.

Germline mutations in pancreatic cancer become better defined.

Barton MK.

CA Cancer J Clin. 2016 Mar-Apr;66(2):93-4. doi: 10.3322/caac.21300. Epub 2016 Jan 11. No abstract available.

22.

Nicotinamide found to reduce the rate of nonmelanoma skin cancers in high-risk patients.

Barton MK.

CA Cancer J Clin. 2016 Mar-Apr;66(2):91-2. doi: 10.3322/caac.21299. Epub 2016 Jan 11. No abstract available.

23.

Structured palliative care program found to be helpful for caregivers of patients with lung cancer.

Barton MK.

CA Cancer J Clin. 2016 Jan-Feb;66(1):5-6. doi: 10.3322/caac.21297. Epub 2015 Nov 23. No abstract available.

24.

Earlier adjuvant therapy is beneficial in patients with breast and colon cancer.

Barton MK.

CA Cancer J Clin. 2016 Jan-Feb;66(1):3-5. doi: 10.3322/caac.21296. Epub 2015 Nov 23. No abstract available.

25.

Enrolling patients into genomically matched clinical trials found challenging.

Barton MK.

CA Cancer J Clin. 2015 Nov-Dec;65(6):425-6. doi: 10.3322/caac.21316. Epub 2015 Sep 9. No abstract available.

26.

Skin self-examination for concerning pigmented lesions appears to be consistent with dermatologist examination.

Barton MK.

CA Cancer J Clin. 2015 Nov-Dec;65(6):423-4. doi: 10.3322/caac.21315. Epub 2015 Sep 9. No abstract available.

27.

Patients of all ages with advanced non-small cell lung cancer are not receiving chemotherapy.

Barton MK.

CA Cancer J Clin. 2015 Sep-Oct;65(5):337-8. doi: 10.3322/caac.21290. Epub 2015 Jul 14. Review. No abstract available.

28.

Mastectomy and breast-conserving therapy confer equivalent outcomes in young women with early-stage breast cancer.

Barton MK.

CA Cancer J Clin. 2015 Sep-Oct;65(5):335-6. doi: 10.3322/caac.21289. Epub 2015 Jul 14. Review. No abstract available.

29.

Integration of lung cancer screening into practice is lacking.

Barton MK.

CA Cancer J Clin. 2015 Jul-Aug;65(4):255-6. doi: 10.3322/caac.21282. Epub 2015 May 5. No abstract available.

30.

Trends in the treatment of early-stage Hodgkin lymphoma.

Barton MK.

CA Cancer J Clin. 2015 Jul-Aug;65(4):253-4. doi: 10.3322/caac.21281. Epub 2015 May 5. No abstract available.

31.

Inferior cancer outcomes more common for uninsured and Medicaid patients.

Barton MK.

CA Cancer J Clin. 2015 May-Jun;65(3):165-6. doi: 10.3322/caac.21270. Epub 2015 Mar 3. No abstract available.

32.

Metastasectomy on the rise across several cancer types.

Barton MK.

CA Cancer J Clin. 2015 May-Jun;65(3):163-4. doi: 10.3322/caac.21269. Epub 2015 Mar 3. No abstract available.

33.

Electronic cigarettes did not help patients with cancer stop smoking.

Barton MK.

CA Cancer J Clin. 2015 Mar;65(2):85-6. doi: 10.3322/caac.21264. Epub 2015 Jan 30. No abstract available.

34.

Daily aspirin may reduce mortality from prostate cancer with risk of high recurrence.

Barton MK.

CA Cancer J Clin. 2015 Mar;65(2):83-4. doi: 10.3322/caac.21263. Epub 2015 Jan 30. No abstract available.

35.

Screening mammography after autologous breast reconstruction is not beneficial.

Barton MK.

CA Cancer J Clin. 2015 Jan-Feb;65(1):3-4. doi: 10.3322/caac.21256. Epub 2014 Dec 22. No abstract available.

36.

Retreatment with rituximab offers a similar survival benefit as maintenance therapy in patients with low tumor burden follicular lymphoma.

Barton MK.

CA Cancer J Clin. 2015 Jan-Feb;65(1):1-2. doi: 10.3322/caac.21255. Epub 2014 Dec 22. No abstract available.

37.

Local leadership and the Affordable Care Act.

Williams SL, Nichols BL, Barton MK, De LaCruz M, Hernandez B.

J Public Health Manag Pract. 2015 Jan-Feb;21 Suppl 1:S87-92. doi: 10.1097/PHH.0000000000000139.

38.

Indoor tanning increases melanoma risk, even in the absence of a sunburn.

Barton MK.

CA Cancer J Clin. 2014 Nov-Dec;64(6):367-8. doi: 10.3322/caac.21248. Epub 2014 Sep 24. No abstract available.

39.

False elevations of carcinoembryonic antigen levels are common in patients under surveillance for colorectal cancer recurrence.

Barton MK.

CA Cancer J Clin. 2014 Nov-Dec;64(6):365-6. doi: 10.3322/caac.21247. Epub 2014 Sep 24. No abstract available.

40.

No cost or safety advantage to robot-assisted radical prostatectomy compared with open-procedure surgery for patients with prostate cancer.

Barton MK.

CA Cancer J Clin. 2014 Sep-Oct;64(5):293-4. doi: 10.3322/caac.21241. Epub 2014 Jul 15. No abstract available.

41.

Oncologists and primary care physicians infrequently provide survivorship care plans.

Barton MK.

CA Cancer J Clin. 2014 Sep-Oct;64(5):291-2. doi: 10.3322/caac.21240. Epub 2014 Jul 15. No abstract available.

42.

Early outpatient referral to palliative care services improves end-of-life care.

Barton MK.

CA Cancer J Clin. 2014 Jul-Aug;64(4):223-4. doi: 10.3322/caac.21230. Epub 2014 May 28. No abstract available.

43.

Prostate cancer screening rates remain stable despite recommendations against testing men with limited life expectancy.

Barton MK.

CA Cancer J Clin. 2014 Jul-Aug;64(4):221-2. doi: 10.3322/caac.21229. Epub 2014 May 28. No abstract available.

44.

Bevacizumab in neoadjuvant chemotherapy increases the pathological complete response rate in patients with triple-negative breast cancer.

Barton MK.

CA Cancer J Clin. 2014 May-Jun;64(3):155-6. doi: 10.3322/caac.21223. Epub 2014 Mar 17. No abstract available.

45.

Growth factor therapy may have a clinical benefit for patients with cancer with established febrile neutropenia.

Barton MK.

CA Cancer J Clin. 2014 May-Jun;64(3):153-4. doi: 10.3322/caac.21222. Epub 2014 Mar 17. No abstract available.

46.

Arabidopsis KANADI1 acts as a transcriptional repressor by interacting with a specific cis-element and regulates auxin biosynthesis, transport, and signaling in opposition to HD-ZIPIII factors.

Huang T, Harrar Y, Lin C, Reinhart B, Newell NR, Talavera-Rauh F, Hokin SA, Barton MK, Kerstetter RA.

Plant Cell. 2014 Jan;26(1):246-62. doi: 10.1105/tpc.113.111526. Epub 2014 Jan 24.

47.

Fecal occult blood testing remains a valuable screening tool.

Barton MK.

CA Cancer J Clin. 2014 Jan-Feb;64(1):3-4. doi: 10.3322/caac.21207. Epub 2013 Nov 8. No abstract available.

48.

No gains in efficacy observed by adding gemcitabine to adjuvant therapy for lymph node-positive breast cancer.

Barton MK.

CA Cancer J Clin. 2014 Jan-Feb;64(1):1-2. doi: 10.3322/caac.21206. Epub 2013 Nov 8. No abstract available.

49.

Affordable oncologic care: a challenging goal.

Barton MK.

CA Cancer J Clin. 2014 Mar-Apr;64(2):75-8. doi: 10.3322/caac.21216. Epub 2014 Jan 13. No abstract available.

50.

High morbidity and mortality found for high-risk, non-muscle-invasive bladder cancer.

Barton MK.

CA Cancer J Clin. 2013 Nov-Dec;63(6):371-2. doi: 10.3322/caac.21201. Epub 2013 Oct 7. No abstract available.

Supplemental Content

Loading ...
Support Center